main-img
Back to Home » January 2021 News » Nanoform's Clinical Study Indicates Positive Interim Results

Nanoform's Clinical Study Indicates Positive Interim Results

January 22, 2021

HELSINKI, Jan. 22, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful. Nanoform has...

Source URL: https://www.prnewswire.com:443/news-releases/nanoforms-clinical-study-indicates-positive-interim-results-301213028.html
Browse News